Filter
614
Text search:
FDA
Featured
Recommendations
81
New Publications
121
Language
Document type
No document type
303
Guidelines
160
Studies & Reports
75
Manuals
24
Fact sheets
24
Strategic & Response Plan
13
Training Material
7
Resource Platforms
3
Brochures
2
Situation Updates
2
Infographics
1
Countries / Regions
India
29
Ghana
17
Latin America and the Carribbean
17
Russia
17
Philippines
12
Myanmar / Burma
12
South Africa
9
Middle East and North Africa
9
USA
8
Kenya
8
Brazil
8
Global
8
Nigeria
7
Congo, Democratic Republic of
7
Germany
7
Syria
7
Argentina
7
West and Central Africa
7
Senegal
6
Uganda
6
Ukraine
6
Colombia
6
Ecuador
6
Yemen
6
Western and Central Europe
6
South Sudan
5
Angola
5
Paraguay
5
Eastern Europe
5
Burkina Faso
4
Liberia
4
Mali
4
Ethiopia
4
Indonesia
4
Mozambique
4
Sudan
4
Peru
4
Eastern Europe and Central Asia
4
Guinea
3
Sierra Leone
3
Nepal
3
Tanzania
3
Thailand
3
Bangladesh
3
Bolivia
3
East and Southern Africa
3
South–East Asia Region
3
Africa
3
Venezuela
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Iraq
2
Jordan
2
Rwanda
2
Namibia
2
El Salvador
2
Chile
2
Asia
2
Albania
2
Tajikistan
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Somalia
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
Mauritania
1
Singapore
1
Malawi
1
Benin
1
Dominican Republic
1
Cuba
1
Honduras
1
Botswana
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Armenia
1
Congo-Brazzaville
1
Qatar
1
Moldova
1
Kazakhstan
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
190
Clinical Guidelines
80
Pharmacy & Technologies
22
Women & Child Health
17
Public Health
11
Key Resources
8
Capacity Building
2
Toolboxes
COVID-19
136
Mental Health
69
TB
59
HIV
48
Pharmacy
35
AMR
30
Ebola
28
Rapid Response
17
Specific Hazards
13
NTDs
10
Zika
8
Refugee
7
NCDs
7
Planetary Health
6
Cholera
3
Conflict
3
Natural Hazards
3
Caregiver
3
Global Health Education
2
Disability
1
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of
...
Three Years After Enactment of the Drug Quality and Security Act
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe
...
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informati
...
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of prod
...
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Annex to Selection and use of Ebola in vitro diagnostic assays
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.